HK1222332A1 - 治療肝臟疾病的方法 - Google Patents

治療肝臟疾病的方法

Info

Publication number
HK1222332A1
HK1222332A1 HK16110571.8A HK16110571A HK1222332A1 HK 1222332 A1 HK1222332 A1 HK 1222332A1 HK 16110571 A HK16110571 A HK 16110571A HK 1222332 A1 HK1222332 A1 HK 1222332A1
Authority
HK
Hong Kong
Prior art keywords
inhibiting
liver disease
liver
disease
Prior art date
Application number
HK16110571.8A
Other languages
English (en)
Inventor
Ing-Jun Chen
Original Assignee
Jansfat Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jansfat Biotechnology Co Ltd filed Critical Jansfat Biotechnology Co Ltd
Publication of HK1222332A1 publication Critical patent/HK1222332A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16110571.8A 2014-09-02 2016-09-06 治療肝臟疾病的方法 HK1222332A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462044593P 2014-09-02 2014-09-02

Publications (1)

Publication Number Publication Date
HK1222332A1 true HK1222332A1 (zh) 2017-06-30

Family

ID=54106121

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110571.8A HK1222332A1 (zh) 2014-09-02 2016-09-06 治療肝臟疾病的方法

Country Status (4)

Country Link
EP (1) EP2992885A3 (zh)
CN (1) CN105380949A (zh)
HK (1) HK1222332A1 (zh)
TW (1) TW201613600A (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3241552A1 (en) * 2016-05-02 2017-11-08 Jansfat Biotechnology Co., Ltd. Compositions and methods for lipid metabolism disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
GB0202254D0 (en) * 2002-01-31 2002-03-20 Pfizer Ltd Prevention of scarring
WO2008124505A2 (en) * 2007-04-05 2008-10-16 Ironwood Pharmaceuticals,Inc. Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
TWI462739B (zh) * 2010-11-02 2014-12-01 Univ Kaohsiung Medical Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途
TWI542350B (zh) * 2011-09-06 2016-07-21 高雄醫學大學 Ｋｍｕｐ複合銨鹽類及高分子聚合物之改善高脂血及體重失衡療效
MX2016011063A (es) * 2014-02-27 2016-11-30 Nusirt Sciences Inc Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica.

Also Published As

Publication number Publication date
TW201613600A (en) 2016-04-16
EP2992885A3 (en) 2016-05-18
CN105380949A (zh) 2016-03-09
EP2992885A2 (en) 2016-03-09

Similar Documents

Publication Publication Date Title
GB201406151D0 (en) Method
GB201406155D0 (en) Method
GB201413240D0 (en) Method
SG11201609350XA (en) Methods for inhibiting necroptosis
IL249868A0 (en) method
HUE053058T2 (hu) Eljárás állatok helyének meghatározására
PL3196196T3 (pl) Sposób wytwarzania kalcobutrolu
PL3094519T3 (pl) Lampa, jak również sposób wykorzystania takiej lampy
ZA201608777B (en) Method for preparing methyl mercaptan
HK1244039A1 (zh) 打樁方法
PL3169844T3 (pl) Sposób zapobiegania tworzeniu się kamienia kotłowego
GB201403470D0 (en) Method
GB201402036D0 (en) Method for determination of the status of a disease
GB201420832D0 (en) Location method
PL3201391T3 (pl) Sposób przetwarzania słomy
GB2538030B (en) Up-drawing casting method
HK1222332A1 (zh) 治療肝臟疾病的方法
GB2528750B (en) Method for integrally forming a sole with hobnails
GB201522624D0 (en) A method
GB201521650D0 (en) A method
ZA201604816B (en) Method for producing a component
PL3137689T3 (pl) Sposób wykonania ściany ze stabilizowanej ziemi
ZA201502004B (en) A method for tracking a vehicle
GB201420242D0 (en) A cross-contamination prevention method
GB201407948D0 (en) Method